Intestinal Diseases  >>  NGC-capecitabine (PCS6422)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGC-capecitabine (PCS6422) / Processa Pharma
NCT00003873: Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer

Completed
3
950
US
fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, eniluracil, 776C85, ADH300004, ethynyluracil, GW776, GW776C85
National Cancer Institute (NCI)
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
07/07
 

Download Options